![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Paresis - 146 Studies Found
Recruiting |
: Raltegravir for HAM/TSP : HTLV-I Infection : 2013-05-21 : Drug: Raltegravir |
Completed |
: Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) :
|
Completed |
: Assessment of Patients With Multiple Sclerosis (MS) :
|
Completed |
: Physiologic Studies of Spasticity :
: 2001-04-17 |
Completed |
: Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis :
|
Completed |
: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial : HTLV-I-associated Myelopathy : 2006-01-04 : Drug: Zidovudine/lamivudine |
Completed |
: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV-I-Associated Myelopathy : 2011-04-25 : Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis : Tropical Spastic Paraparesis : 2002-05-01 |
Completed |
: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV I Associated Myelopathy : 2008-10-15 : Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Not yet recruiting |
: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection :
: 2015-11-16 : Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |